| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1 Internal Medicine, 2 Integrative Biology, and 3 Surgery, Trauma Research Center, University of Texas Health Science Center, Houston, Texas 77030
Gastrointestinal stasis during sepsis may be
associated with gastrointestinal smooth muscle dysfunction. Endotoxin
[lipopolysaccharide (LPS)] impairs smooth muscle
contraction, in part through inducible nitric oxide synthase (NOS II)
and enhanced nitric oxide production. We studied the roles of tumor
necrosis factor-
(TNF) and interleukin-1 (IL-1) in this process by
using TNF binding protein (TNFbp) and IL-1 receptor antagonist
(IL-1ra). Rats were treated with TNFbp and IL-1ra, or their vehicles, 1 h before receiving LPS or saline. At 5 h after LPS, contractility was
measured in strips of ileal longitudinal smooth muscle, and NOS II
activity was measured in full-thickness segments of ileum. LPS
decreased maximum stress (mean ± SE) from 508 ± 55 (control) to
355 ± 33 g/cm2
(P < 0.05). Pretreatment with TNFbp
plus IL-1ra prevented the LPS-induced decrease. Separate studies of
TNFbp alone or IL-1ra alone indicated that, at the doses and timing
used, TNFbp was more effective. LPS also increased NOS II activity by
>10-fold (P < 0.01) over control.
This increase was prevented by TNFbp plus IL-1ra
(P = not significant vs. control). We
conclude that the LPS-induced increase in NOS II activity and the
decrease in ileal muscle contractility are mediated by TNF and IL-1.
tumor necrosis factor; interleukin-1; tumor necrosis factor binding protein; interleukin-1 receptor antagonist; soluble tumor necrosis factor receptors; sepsis; nitric oxide; inducible nitric oxide synthase; nitric oxide synthase activity; intestinal transit; endotoxin; ileal smooth muscle
This article has been cited by other articles:
|
|
 |
|
  M. Hori, H. Nobe, K. Horiguchi, and H. Ozaki MCP-1 targeting inhibits muscularis macrophage recruitment and intestinal smooth muscle dysfunction in colonic inflammation Am J Physiol Cell Physiol, February 1, 2008; 294(2): C391 - C401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hu, S. Mahavadi, F. Li, and K. S. Murthy Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1 Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1991 - C2000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Overhaus, S. Togel, M. A. Pezzone, and A. J. Bauer Mechanisms of polymicrobial sepsis-induced ileus Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G685 - G694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Mutlu, E. A. Mutlu, and P. Factor GI Complications in Patients Receiving Mechanical Ventilation Chest, April 1, 2001; 119(4): 1222 - 1241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Turler, N. T. Schwarz, E. Turler, J. C. Kalff, and A. J. Bauer MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat Am J Physiol Gastrointest Liver Physiol, January 1, 2002; 282(1): G145 - G155. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
